What HALOZYME THERAPEUTICS, INC.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 43 | 106 |
| Total trades | 57 | 185 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 220,000 | 778,625 |
| Disposed | 244,226 | 720,903 |
| Net activity | −24,226 | +57,722 |
Common stock only — 3 reported trades in the last 12 months are in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Torley Helen | PRESIDENT AND CEO | Nov 16 | Open-market sale · S | −188 | $101.72 | −$19.1K | 767,780 |
| Torley Helen | PRESIDENT AND CEO | Nov 16 | Open-market sale · S | −1,244 | $101.06 | −$126K | 767,968 |
| Torley Helen | PRESIDENT AND CEO | Nov 16 | Open-market sale · S | −4,897 | $100.10 | −$490K | 769,212 |
| Torley Helen | PRESIDENT AND CEO | Nov 16 | Open-market sale · S | −1,586 | $98.89 | −$157K | 774,109 |
| Torley Helen | PRESIDENT AND CEO | Nov 16 | Open-market sale · S | −4,802 | $97.96 | −$470K | 775,695 |
| Torley Helen | PRESIDENT AND CEO | Nov 16 | Open-market sale · S | −7,283 | $96.85 | −$705K | 780,497 |
| Torley Helen | PRESIDENT AND CEO | Nov 16 | Exercise / conversion · M | +20,000 | $16.65 | +$333K | 787,780 |
| Torley Helen | PRESIDENT AND CEO | Nov 13 | Open-market sale · S | −12,008 | $100.61 | −$1.21M | 767,780 |
| Torley Helen | PRESIDENT AND CEO | Nov 13 | Open-market sale · S | −7,992 | $100.02 | −$799K | 779,788 |
| Torley Helen | PRESIDENT AND CEO | Nov 13 | Exercise / conversion · M | +18,448 | $16.65 | +$307K | 787,780 |
| Torley Helen | PRESIDENT AND CEO | Nov 13 | Exercise / conversion · M | +1,552 | $18.41 | +$28.6K | 769,332 |
| Torley Helen | PRESIDENT AND CEO | Nov 12 | Open-market sale · S | −9,289 | $101.49 | −$943K | 767,780 |
| Torley Helen | PRESIDENT AND CEO | Nov 12 | Open-market sale · S | −10,711 | $101.09 | −$1.08M | 777,069 |
| Torley Helen | PRESIDENT AND CEO | Nov 12 | Exercise / conversion · M | +20,000 | $18.41 | +$368K | 787,780 |
| Torley Helen | PRESIDENT AND CEO | Oct 08 | Open-market sale · S | −200 | $110.51 | −$22.1K | 767,780 |
| Torley Helen | PRESIDENT AND CEO | Oct 08 | Open-market sale · S | −11,900 | $110.00 | −$1.31M | 767,980 |
| Torley Helen | PRESIDENT AND CEO | Oct 08 | Open-market sale · S | −3,090 | $108.91 | −$337K | 779,880 |
| Torley Helen | PRESIDENT AND CEO | Oct 08 | Open-market sale · S | −4,810 | $108.18 | −$520K | 782,970 |
| Torley Helen | PRESIDENT AND CEO | Oct 08 | Exercise / conversion · M | +20,000 | $18.41 | +$368K | 787,780 |
| Torley Helen | PRESIDENT AND CEO | Oct 07 | Open-market sale · S | −200 | $113.69 | −$22.7K | 767,780 |
Loading...